OxiGene Inc (OXGN)

0.71
0.06 9.23
NASDAQ : Health Care
Prev Close 0.65
Open 0.67
Day Low/High 0.67 / 0.72
52 Wk Low/High 0.49 / 1.40
Volume 135.33K
Avg Volume 534.20K
Exchange NASDAQ
Shares Outstanding 26.54M
Market Cap 18.58M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data

Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data

An analysis of results from Oxigene's phase II study of fosbretabulin plus Avastin in recurrent ovarian cancer.

Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta

Biotech Stock Mailbag: Rockwell Medical, Oxigene, Prosensa, Sarepta

Biotech columnist Adam Feuerstein answers readers' questions about health care.

3 Biotech Stocks Under $10 in Breakout Territory

3 Biotech Stocks Under $10 in Breakout Territory

Keep these under-$10 biotech stocks on your breakout trading radar.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

OXiGENE, Inc. Announces $16 Million At-The-Market Registered Direct Offering

OXiGENE, Inc. Announces $16 Million At-The-Market Registered Direct Offering

Company Significantly Strengthens Cash Position

First Week of OXGN June 21st Options Trading

First Week of OXGN June 21st Options Trading

Investors in OXiGENE, Inc. saw new options become available this week, for the June 21st expiration.

OxiGene (OXGN) In A Perilous Reversal

OxiGene (OXGN) In A Perilous Reversal

Trade-Ideas LLC identified OxiGene (OXGN) as a "perilous reversal" (up big yesterday but down big today) candidate

3 Biotech Stocks Under $10 to Trade

3 Biotech Stocks Under $10 to Trade

Keep your eye on these under-$10 biotech stocks.

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

OXGN October 18th Options Begin Trading

OXGN October 18th Options Begin Trading

Investors in OXiGENE, Inc. saw new options begin trading today, for the October 18th expiration.

OxiGene (OXGN) Marked As A Dead Cat Bounce Stock

OxiGene (OXGN) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified OxiGene (OXGN) as a "dead cat bounce" (down big yesterday but up big today) candidate